| 000 | 01641 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513220237.0 | ||
| 264 | 0 | _c20001103 | |
| 008 | 200011s 0 0 eng d | ||
| 022 | _a0028-3908 | ||
| 024 | 7 |
_a10.1016/s0028-3908(00)00058-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDutton, J L | |
| 245 | 0 | 0 |
_aP2X(1) receptor membrane redistribution and down-regulation visualized by using receptor-coupled green fluorescent protein chimeras. _h[electronic resource] |
| 260 |
_bNeuropharmacology _cAug 2000 |
||
| 300 |
_a2054-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xpharmacology |
| 650 | 0 | 4 |
_aAdenoviridae _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aGreen Fluorescent Proteins |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndicators and Reagents _xmetabolism |
| 650 | 0 | 4 |
_aLuminescent Proteins _xmetabolism |
| 650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2 _xdrug effects |
| 650 | 0 | 4 | _aReceptors, Purinergic P2X |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xgenetics |
| 650 | 0 | 4 |
_aTranscription, Genetic _xgenetics |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aXenopus |
| 700 | 1 | _aPoronnik, P | |
| 700 | 1 | _aLi, G H | |
| 700 | 1 | _aHolding, C A | |
| 700 | 1 | _aWorthington, R A | |
| 700 | 1 | _aVandenberg, R J | |
| 700 | 1 | _aCook, D I | |
| 700 | 1 | _aBarden, J A | |
| 700 | 1 | _aBennett, M R | |
| 773 | 0 |
_tNeuropharmacology _gvol. 39 _gno. 11 _gp. 2054-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0028-3908(00)00058-7 _zAvailable from publisher's website |
| 999 |
_c10911262 _d10911262 |
||